tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ:GLUE
US Market

Compare Monte Rosa Therapeutics (GLUE) vs. Competitors

Compare
363 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Monte Rosa Therapeutics
$24.06
$1.83B
78.78
332.73%
8 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$4.30
$728.57M
10.28
411.30%
5 Buy
1 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$10.25
$683.45M
-8.79
155.17%
9 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$69.60
$465.11M
178.62%
11 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.10B
-7.42
496.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GLUE
Monte Rosa Therapeutics
24.06
17.82
285.58%
CTMX
CytomX Therapeutics
4.30
3.44
400.00%
FULC
Fulcrum Therapeutics
10.36
6.26
152.68%
MNPR
Monopar Therapeutics Inc
69.60
42.69
158.64%
OPT
INBX
Inhibrx Biosciences Inc
75.93
62.46
463.70%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts